HomeGeneticsConditionHIVEP2-related intellectual disability
Back to Condition
HIVEP2-related intellectual disability
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

HIVEP2-related intellectual disability

HIVEP2-related intellectual disability is a rare neurological disorder caused by mutations in the HIVEP2 gene, characterized by moderate to severe developmental delay, intellectual disability, and mild physical abnormalities.

Overview

HIVEP2-related intellectual disability is a neurological disorder characterized by moderate to severe developmental delay and intellectual disability, along with mild physical abnormalities (dysmorphic features). This condition is rare, with at least nine individuals described in the medical literature.

Symptoms

Early symptoms of the condition include weak muscle tone (hypotonia) and delayed development of motor skills, such as sitting, standing, and walking. After learning to walk, many affected individuals continue to have difficulty with this activity; their walking style (gait) is often unbalanced and wide-based. Speech is also delayed, and some people with this condition never learn to talk.

Most people with HIVEP2-related intellectual disability exhibit neurodevelopmental disorders, which may include:

  • Hyperactivity
  • Attention deficit disorder
  • Aggression
  • Anxiety
  • Autism spectrum disorder, a group of developmental disorders characterized by impaired communication and social interaction

Other features of the condition include mild abnormalities in the structure of the brain and an abnormally small brain and head size (microcephaly). Less common health problems include:

  • Seizures
  • Recurrent ear infections
  • Eye disorders, such as eyes that do not look in the same direction (strabismus), "lazy eye" (amblyopia), and farsightedness (hyperopia)
  • Gastrointestinal problems, which can include backflow of acidic stomach contents into the esophagus (gastroesophageal reflux) and constipation

Many people with the condition also have unusual physical features, such as widely spaced eyes, although there is no characteristic pattern of such features among affected individuals.

Causes & Risk Factors

HIVEP2-related intellectual disability is caused by mutations in the HIVEP2 gene. The protein produced from this gene is most abundant in the brain, where it controls the activity (expression) of genes involved in brain growth and development.

Mutations in the HIVEP2 gene are thought to lead to a shortage of functional HIVEP2 protein. It is unclear how these genetic changes result in the features associated with the condition, although researchers speculate that a shortage of the HIVEP2 protein alters the expression of several genes involved in brain growth and development. Abnormalities in the growth and development of the brain likely underlie the cognitive problems and other neurological features of HIVEP2-related intellectual disability. It is unclear how HIVEP2 gene mutations contribute to the unusual physical features and health problems that can occur with this condition.

Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Most cases of this condition result from new (de novo) mutations in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual’s parent or in early embryonic development. These cases occur in people with no history of the disorder in their family.

Other Names

  • Mental retardation, autosomal dominant 43
  • MRD43

Frequently Asked Questions

Seizure types vary, but most respond to standard antiepileptic drugs (e.g., levetiracetam, valproic acid). A neurologist will tailor medication based on EEG findings and seizure frequency. Regular monitoring for side effects and periodic EEGs are important, and a rescue medication plan should be in place for breakthrough seizures.
Begin PT as soon as the child can sit with support, typically before 12 months of age. Early goals focus on improving trunk control, facilitating independent sitting, and promoting a stable gait pattern. Over time, therapy aims to increase endurance, balance, and functional mobility for activities such as climbing stairs or navigating uneven surfaces.
Speech delay is common; many children benefit from early intensive speech‑language therapy combined with augmentative communication (e.g., picture exchange or speech‑generating devices). Consistent therapy, parental modeling, and a low‑stress communication environment can lead to functional speech in many individuals, though some may rely on alternative communication methods throughout life.
targeted gene panel for neurodevelopmental disorders that includes HIVEP2, or whole‑exome sequencing, can identify pathogenic variants. Confirmation is usually done by Sanger sequencing of the identified variant and, if needed, parental testing to determine inheritance.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA